Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the Study Record Versions. Removed the older funding-status notice and Revision: v3.4.1.SummaryDifference0.9%

- Check21 days agoChange DetectedAdded a government funding notice and a new revision tag (v3.4.1) to the Record History; the previous revision (v3.4.0) was removed.SummaryDifference0.9%

- Check28 days agoChange DetectedUI updates include showing the glossary, color-coded additions and deletions in the history, and a new revision label (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed on the Record History page, reflecting metadata updates to the record history rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry Revision: v3.3.3 was added to the Study Record History; the HHS Vulnerability Disclosure link was removed and Revision: v3.3.2 is no longer listed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe record history shows a new revision (v3.3.2) and the removal of an older revision (v3.2.0) for the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.